Elevated glutathione as a therapeutic strategy in Alzheimer's disease
- 1 July 2002
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 56 (3) , 428-437
- https://doi.org/10.1002/ddr.10095
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- DiscussionNeurobiology of Aging, 1999
- Protein‐Bound AcroleinJournal of Neurochemistry, 1999
- A Phase I/II Evaluation of Oral L-2-Oxothiazolidine-4-Carboxylic Acid in Asymptomatic Patients Infected with Human Immunodeficiency VirusThe Journal of Clinical Pharmacology, 1998
- Preventive effect of γ-glutamylcysteinylethyl ester on carbon tetrachloride-induced hepatic triglyceride accumulation in miceToxicology Letters, 1998
- A Laser Microprobe Mass Analysis of Brain Aluminum and Iron in Dementia pugilistica: Comparison with Alzheimer's DiseaseEuropean Neurology, 1997
- Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 1996
- Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brainNeuroscience Letters, 1996
- Conversion of γ-glutamylcysteinylethyl ester to glutathione in rat hepatocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Laser microprobe analysis of brain aluminum in Alzheimer' diseaseAnnals of Neurology, 1993
- N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolismInternational Journal of Immunopharmacology, 1988